Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry

Depression and Anxiety

Volumn 12, Issue 3, 2000, Pages 135-143

  McDonald, William M ^a   Greenberg, Benjamin D ^b  

^a EMORY UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Electroconvulsive therapy; Neurological disorders; Neuropsychiatric disorders; Neuropsychiatry; Obsessive compulsive disorders; Transcranial magnetic stimulation

Indexed keywords

ARTICLE; BRAIN CORTEX; BRAIN DISEASE; BRAIN REGION; CEREBRAL PALSY; COGNITION; ELECTROCONVULSIVE THERAPY; EPILEPSY; HUMAN; HUNTINGTON CHOREA; INTERMETHOD COMPARISON; MENTAL DISEASE; MORBIDITY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROPSYCHIATRY; OBSESSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOPHARMACOTHERAPY; SEIZURE; TARDIVE DYSKINESIA; TRANSCRANIAL MAGNETIC STIMULATION;

BRAIN DISEASES; BRAIN MAPPING; CEREBRAL CORTEX; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; ELECTROCONVULSIVE THERAPY; ELECTROMAGNETIC FIELDS; HUMANS; SENSITIVITY AND SPECIFICITY; SYNAPTIC TRANSMISSION;

EID: 0033667879     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6394(2000)12:3<135::AID-DA5>3.0.CO;2-4     Document Type: Article

References (74)

1. Maintenance electroconvulsive therapy for Parkinson disease
2. ECT for Parkinson's disease
3. A double-blind evaluation of electroconvulsive therapy in Parkinson disease with 'on-off' phenomena
4. A single-blind study of ECT in patients with tardive dyskinesia
5. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging
6. Electroconvulsive therapy in Parkinson syndrome with 'on-off' phenomenon
7. Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy
8. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects
9. Caudate glucose metabolic rate changes with drug and behavior therapy for obsessive-compulsive disorder
10. ECT for the treatment of Huntington disease: A case study
11. Treatment of epilepsy by electrically induced convulsions: A preliminary report
12. Electrical convulsion therapy in treatment of epilepsy
13. ECT and tardive dyskinesia: Two cases and a review
14. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder
15. Electroconvulsive therapy in the treatment of neuroleptic malignant syndrome
16. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors: Relevance to treatment of obsessive-compulsive disorder
17. ECT in Parkinson disease. Changes in motor symptoms, monoamine metabolites and neuropeptides
18. Simultaneous major depression and panic disorder: Treatment with electroconvulsive therapy
19. Electroconvulsive therapy
20. Convulsive therapy for Parkinson disease?
21. Observation on the effects of electroshock treatment in patients with parkinsonism
22. Children with Sydenham Chorea have decreased cortical post-excitatory inhibition
23. rTMS studies of mood and emotion
24. Repetitive transcranial magnetic stimulation does not improve performance on the grooved pegboard task in Parkinson disease
25. Electroconvulsive therapy for status epilepticus
26. Improvement of tardive dyskinesia associated with electroconvulsive therapy
27. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A preliminary study
28. Reduced intracortical inhibition in obsessive-compulsive disorder on transcranial magnetic stimulation
29. Electroconvulsive therapy for treatment of intractable seizures: Initial findings in two children
30. Initial experience with electroconvulsive therapy for progressive supranuclear palsy
31. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients
32. Psychobiology of obsessive-compulsive disorder: Anatomical and physiological considerations
33. Effects of electroconvulsive therapy on mood parkinsonism and tardive dyskinesia in a depressed patient: ECT and the dopamine systems
34. Maintenance ECT for refractory obsessive-compulsive disorder
35. Toward a neuroanatomy of obsessive-compulsive disorder
36. Progressive supranuclear palsy: Clinico-pathological and biochemical studies
37. Observations in electric shock therapy applied to problems of epilepsy
38. Electroconvulsive therapy and Parkingson's disease: The case for further study
39. Neuropsychiatric considerations in the use of electroconvulsive therapy
40. Pathogenesis of Tourette syndrome
41. Tardive dyskinesia and electroconvulsive therapy
42. Refractory obsessive compulsive disorder and ECT
43. Multiple ECT late in the course of neuroleptic malignant syndrome
44. Successful treatment with obsessive-compulsive disorder with ECT
45. Frontal-subcortical circuits and neuropsychiatric disorders
46. Capsulotomy and cingulotomy as treatments for malignant obsessive compulsive disorder
47. Regional cerebral glucose metabolism in anxiety disorders studied with positron emission tomography before and after psychosurgical intervention. A preliminary report
48. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder
49. Increased responsiveness of dopamine receptors after ECT: A review of experimental and clinical evidence
50. Prolonged unconsciousness following electroconvulsive therapy
51. The neurobiology of ECT: Animal studies
52. Transcranial magnetic stimulation: A new tool for the study of higher cognitive functions in humans
53. Akinesia in Parkinson disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulation
54. Biological treatments for obsessive-compulsive disorder; literature review
55. Electroconvulsive therapy as an anticonvulsant: Implications for its mechanism of action in affective illness
56. The effects of electroconvulsive therapy on tardive dyskinesia
57. Basal ganglia dysfunction as a proposed cause of obsessive-compulsive disorder
58. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography
59. Neuroimaging of OCD and related disorders
60. Electroconvulsive therapy for epilepsy and major depression
61. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia
62. Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action
63. Seizure threshold in electroconvulsive therapy: Effects of sex, age, electrode placement, and number of treatments
64. Neuroimaging and frontal-subcortical circuitry in obsessive compulsive disorder
65. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder
66. Five Hz repetitive transcranial magnetic stimulation of the primary motor cortex improves smoothness of fast pointing movements in patients with Parkinson's disease
67. Maintenance electroconvulsive therapy for intractable Parkinson disease
68. The effects of electroconvulsive therapy on tardive dyskinesia: A prospective study
69. ECT for refractory Parkinson disease
70. Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study
71. Decreased motor inhibition in Tourette disorder: Evidence from transcranial magnetic stimulation
72. Transcranial magnetic stimulation: Its current role in epilepsy research